Synopsis
"Nightly Business Report produced by CNBC" (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Televisions longest-running evening business news broadcast, "NBR" features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the worlds top business leaders and policy makers. Co-anchored by award-winning journalists Bill Griffeth and Sue Herera, NBR produced by CNBC will explain the days leading stories in a comprehensive and accessible way to a wide-ranging audience.
Episodes
-
Sell till Summer?, Cloud Concerns, and “Egg-cellent” Picks 1/24/23
24/01/2023 Duration: 45minStocks are giving back yesterday’s gains, and one of our experts is hardly surprised. He says to sell any rally until at least the summer. He’ll join to explain why. Plus, everyone is bracing for tonight’s earnings from Microsoft. We’ll tell you what to look for, and how to position ahead of the big report. And, sky-high egg prices could be a tailwind for one key group of stocks. We’ll reveal the names, and tell you which are most attractive here.
-
A Fed Pause? ‘More Concerned than Ever About China,’ and The Great Tech Reckoning 1/23/23
23/01/2023 Duration: 44minNoted economist Paul McCulley tells us why a pause in Fed rate hikes would be ‘fully justified.’ Yale’s Stephen Roach is more concerned about China than he’s ever been. And layoffs, AI, search battles, oh my…we dig into the reckoning in tech and what’s next for the likes of Google and Microsoft.
-
From the Desk of Kelly Evans: "Leading" us right over a cliff 1/23/23
23/01/2023 Duration: 03minKelly explains why this week’s economic indicators report could spell big trouble ahead for the economy.
-
Follow the Fed Speak, Big Tech Jobs Cuts, and Savings Down, Debt Up 1/20/23
20/01/2023 Duration: 46minIt’s been a big week of Fed speakers dominating headlines, and we’re not done yet. Federal Reserve Governor Christopher Waller is speaking today at the Council of Foreign Relations, and we’ll bring you the key headlines. Plus, Alphabet is joining the list of big tech giants announcing job cuts, set to lay off 12,000 workers. We’ll explore what it all means for the sector after a rough year in 2022. And, the U.S. personal savings rate has plummeted from pandemic-era highs, while household and credit card debt soar to new records. We’ll explain why 2023 could be a rough year for consumers.
-
Emerging Opportunities, the Fed’s Pedal to the Metal, and Three-peat for Oil? 1/19/23
19/01/2023 Duration: 44minWith inflation slowing, but sticking around here in the US, should investors look overseas? Why Europe is beginning to look attractive—and why the Fed needs to pause rate hikes, according to one bond investor. Plus, oil was the top performing sector for two years in a row, could 2023 be a record three-peat? Amrita Sen weighs in with why she’s bullish.
-
Dollar Doldrums, The Next Big Vaccine Race, and Debt Ceiling Showdown 1/18/23
18/01/2023 Duration: 44minThe Bank of Japan is standing pat on its yield curve control policy, and that’s reverberating throughout global markets. We’ll drill down on the decline in the dollar, and the stocks poised to benefit here. Plus, Moderna’s RSV vaccine efficacy is driving the stock higher, and setting the stage for a new post-Covid battleground. We’ll speak to an analyst who says this could be a game changer for $MRNA shares. And, the U.S. is poised to hit its debt ceiling tomorrow, much sooner than expected. And a showdown in Washington could come at a high cost. We’ll look at the potential fallout for markets & the economy.
-
Worst Miss In A Decade, Growing Pains, and Wings, Wheels & Deals 1/17/23
17/01/2023 Duration: 45minBig banks are back in the spotlight today, with Morgan Stanley & Goldman Sachs reporting earnings. And both stocks are taking off in opposite directions. Goldman seeing its biggest miss in a decade…while Morgan topped estimates and reported record wealth management revenue. We’ll break down all the headlines. Plus, a slowing economy, slowing population growth, and a resurgence in Covid cases. We’ll give you the latest news out of China, including what it all means for investing there. And, we’ll give you the action, the story and the trade on United Airlines, J.B. Hunt & Prologis ahead of results on deck in ‘Earnings Exchange.’
-
Growing or Slowing?, Risk Trade Returns, and 3 Buys & A Bail 1/13/23
13/01/2023 Duration: 44minDifferent data points are giving you very different stories about the economy right now. So are we growing, or slowing? We’ll debate. Plus, speaking of which -- “Meme Stocks” are back! Is that a red flag for investors, or a green light for stocks? We’ll ask our experts. And, on the heels of Disney’s proxy fight, we have a very special edition of “3 Buys & A Bail” that you won’t want to miss.
-
From the Desk of Kelly Evans: The Fed pause is nearly at hand 1/12/23
12/01/2023 Duration: 02minKelly explains how a Fed policy pivot could be just around the corner.
-
Fed vs. Markets, “Lost Its Way”, and the Bank Barometer 1/12/23
12/01/2023 Duration: 49minIs a Fed pause now just around the corner? Markets already seem to be coming to that conclusion, and now some FOMC members are signaling it too. We’ll debate. Plus, activist investor Nelson Peltz wants a seat on Disney’s board, saying the company has “lost its way.” We have the latest details, and what it means for the stock. And, bank earnings are on deck, with a much-needed pulse on the economy incoming. Will it expose cracks, or continued strength? We’ll look at what to expect.
-
From the Desk of Kelly Evans: Here comes the headfake 1/12/23
12/01/2023 Duration: 03minKelly explains why the Fed might not be as hawkish as it seems to be.
-
FTX Fallout, Bailing on a Bailout, and an “Extraordinary” Outage 1/11/23
11/01/2023 Duration: 43minFTX is back in bankruptcy court today, as company lawyers claim they’ve recovered over $5 billion worth of ‘liquid’ assets. But that still leaves them about $3 billion short of what customers are owed. We’ve got the latest details. Plus, remember when FTX wanted a bailout? Apollo was one of the firms they turned to. We’ll ask its Co-Head of Private Equity why they ultimately passed on that opportunity. And, another week, another airline mess – this time, an FAA outage grounding flights nationwide. We’ll check in with a veteran pilot who says what we’re seeing today is simply “extraordinary.”
-
From the Desk of Kelly Evans: Do they see what we see? 1/10/23
10/01/2023 Duration: 02minKelly opines on the Fed’s difficult balancing act for 2023.
-
Data Disconnect, Pockets of Opportunity, and Taking (A.I.)M 1/10/23
10/01/2023 Duration: 43minInflation is receding. Jobs & GDP are growing. Even jobless claims are relatively low. And yet, yield curves are flashing a huge warning sign that a downturn is coming. So why isn’t the Fed acknowledging it? We’ll debate. Plus, if you’re looking to deploy some cash in this market, we’ll speak with an expert who says there are 2 sectors to bet on and 2 stocks to buy right now. And, Microsoft is reportedly making another big bet on OpenAI’s ChatGPT program. But so are hackers. We’ve got the latest details.
-
Fed Faux Pas?, Policy Problems, and Far To Fall? 1/9/23
09/01/2023 Duration: 44minDespite myriad signs the economy is slowing, the Fed remains on a pre-set hawkish course. So should they switch and start pausing rate hikes? We’ll reveal the one data point flashing a big warning sign. Plus, the House finally has a Speaker! But the concessions made to get there may not bode well for business. We’ll tell you all that you need to know. And, Apple shares have been a stubborn weak spot in the market lately. But Toni Sacconaghi of Bernstein says they’re still too pricey. He joins us to explain why.
-
Job Market Relief, Biogen’s Big Bet, and Stop Trying to Beat the Market! 1/6/23
06/01/2023 Duration: 44minStocks rallying after wages in December grew at a slower than expected rate. We dig into what it means for the Fed and your money. The FDA expected to decide on Biogen’s second Alzheimer’s treatment, Jefferies’ analyst Michael Yee tells us what makes this drug different than its maligned first drug Aduhelm. Plus, “A Random Walk Down Wall Street” 50 years later. Wall St. legend Burt Malkiel makes his case for passive investing and why investors shouldn’t trust historic returns…especially now.
-
From the Desk of Kelly Evans: The end of FA(A)NG 1/4/23
04/01/2023 Duration: 03minKelly explains why the FANG trade has finally fizzled out.
-
Fed Minutes on Deck, DC Dysfunction, and a Stock Picker’s Dream? 1/4/23
04/01/2023 Duration: 44minIt’s the countdown to the Fed Minutes and everyone is wondering whether there will be signs of a fracture about what the Fed should do next. We’ll get you set up and run through the latest jobs and inflation numbers. Plus, more DC drama as the GOP struggles to elect a House Speaker. We look at why this could set the stage for two years of tail risk, and the potential fallout for the economy and the markets. And, speaking of markets, if you’re stock picker, you can get some high quality names at bargain prices right now. Our market guest brings four of his favorites…and there’s a twist.
-
From the Desk of Kelly Evans: What if the Fed jacked rates up? 1/3/23
03/01/2023 Duration: 02minKelly explains why the effects of the Fed’s tightening in 2022 could finally start to be felt throughout the economy in the new year.
-
Bulls or Bears?, The Case for Commodities, and A Rough Ride 1/3/23
03/01/2023 Duration: 43minLast year was miserable for stocks. And so far, this year is too. One expert says it won’t get better right away, either. But he’s finding opportunity in the wreckage, and one of his top picks is quite contrarian. He’ll join us to explain why. Plus, one oil bull is remaining steadfast. Jeff Currie of Goldman Sachs joins us to explain why he thinks the set-up for commodities could be the best since the start of the ‘super cycle’ in 2020. And, Tesla’s latest deliveries fell short of expectations, and the stock is now down by more than 70% in the past year. So when will Wall Street finally throw in the towel? We’ll speak to an analyst still rating $TSLA a ‘strong buy.’